Chief Operating Officer, MedDev Commercialization Centre for Medical Devices
Richard Meadows was selected by FORBES as one of the top ten Life Science Investors in North America in 2013. He was a Managing Partner with a $100M Life Sciences Fund in Quebec until just recently, and one of its co-founders. He joined the Fund from his previous position as a Venture Partner with VantagePoint Venture Partners, a US$2.8 billion private Equity fund based in San Bruno, California. Richard was also a Partner in the Biotechnology Group of CDP Capital Technology Ventures ($1.2 billion).
Mr. Meadows has extensive experience in operations, clinical development, general management and finance in the biotechnology and medical device sectors. He has made, managed, and exited investments in the cancer, cardiovascular, auto-inflammatory; CNS, orphan disease, orthopaedic, medical diagnostic and immunology areas. He has represented investors on some 20+ Company Boards.
Richard did his undergraduate degree in Biochemistry and a M.Sc. in Cardiovascular Physiology, both from McGill University. Richard is also a graduate of the Rotman School of Management, University of Toronto (MBA).